Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-014051
Filing Date
2023-05-30
Accepted
2023-05-30 16:05:33
Documents
1
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3961
  Complete submission text file 0000899243-23-014051.txt   5484
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Druker Brian (Reporting) CIK: 0001740205 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39244 | Film No.: 23976329

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations